Isotretinoin-induced agranulocytosis

Ozdemir M. A., Kose M., Karakukcu M., FERAHBAS A., Patiroglu T., Koklu E.

PEDIATRIC DERMATOLOGY, vol.24, no.4, pp.425-426, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 4
  • Publication Date: 2007
  • Doi Number: 10.1111/j.1525-1470.2007.00468.x
  • Journal Name: PEDIATRIC DERMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.425-426
  • Erciyes University Affiliated: Yes

Abstract

lsotretinoin is used to treat a spectrum of dermatologic conditions. The present article reports the case of a 15-year-old female patient who exhibited agranulocytosis after the initiation of isotretinoin administration. Agranulocytosis is a rare but life-threatening side effect of isotretinoin use, and clinicians must be aware of agranulocytosis.